Metabotropic glutamate receptors in the basal ganglia motor circuit

被引:259
作者
Conn, PJ
Battaglia, G
Marino, MJ
Nicoletti, F
机构
[1] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Program Translat Neuropharmacol, Nashville, TN 37232 USA
[2] Neuromed, Inst Neurol Mediterraneo, Dept Neuropharmacol, I-86077 Pozzilli, Italy
[3] Merck Res Labs, Movement Disorders, Neurosci Drug Discovery, West Point, PA 19486 USA
[4] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, I-00185 Rome, Italy
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nrn1763
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In recent years there have been tremendous advances in our understanding of the circuitry of the basal ganglia and our ability to predict the behavioural effects of specific cellular changes in this circuit on voluntary movement. These advances, combined with a new understanding of the rich distribution and diverse physiological roles of metabotropic glutamate receptors in the basal ganglia, indicate that these receptors might have a key role in motor control and raise the exciting possibility that they might provide therapeutic targets for the treatment of Parkinson's disease and related disorders.
引用
收藏
页码:787 / 798
页数:12
相关论文
共 147 条
[51]   Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum [J].
Domenici, MR ;
Pepponi, R ;
Martire, A ;
Tebano, MT ;
Potenza, RL ;
Popoli, P .
JOURNAL OF NEUROCHEMISTRY, 2004, 90 (05) :1276-1279
[52]   Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors:: Implications for striatal neuronal function [J].
Ferré, S ;
Karcz-Kubicha, M ;
Hope, BT ;
Popoli, P ;
Burgueño, J ;
Gutiérrez, MA ;
Casadó, V ;
Fuxe, K ;
Goldberg, SR ;
Lluis, C ;
Franco, R ;
Ciruela, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11940-11945
[53]   Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons [J].
Fiorillo, CD ;
Williams, JT .
NATURE, 1998, 394 (6688) :78-82
[54]  
Flor PJ, 2002, ADV EXP MED BIOL, V513, P197
[55]   Cholinergic modulation of neostriatal output:: A functional antagonism between different types of muscarinic receptors [J].
Galarraga, E ;
Hernández-López, S ;
Reyes, A ;
Miranda, I ;
Bermudez-Rattoni, F ;
Vilchis, C ;
Bargas, J .
JOURNAL OF NEUROSCIENCE, 1999, 19 (09) :3629-3638
[56]  
Gasparini F, 1999, J PHARMACOL EXP THER, V289, P1678
[57]   2-methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist [J].
Gasparini, F ;
Lingenhöhl, K ;
Stoehr, N ;
Flor, PJ ;
Heinrich, M ;
Vranesic, I ;
Biollaz, M ;
Allgeier, H ;
Heckendorn, R ;
Urwyler, S ;
Varney, MA ;
Johnson, EC ;
Hess, SD ;
Rao, SP ;
Sacaan, AI ;
Santori, EM ;
Veliçelebi, G ;
Kuhn, R .
NEUROPHARMACOLOGY, 1999, 38 (10) :1493-1503
[58]   Postsynaptic endocannabinoid release is critical to long-term depression in the striatum [J].
Gerdeman, GL ;
Ronesi, J ;
Lovinger, DM .
NATURE NEUROSCIENCE, 2002, 5 (05) :446-451
[59]   Are ubiquitination pathways central to Parkinson's disease? [J].
Giasson, BI ;
Lee, VMY .
CELL, 2003, 114 (01) :1-8
[60]   Parkinson's - Divergent causes, convergent mechanisms [J].
Greenamyre, JT ;
Hastings, TG .
SCIENCE, 2004, 304 (5674) :1120-1122